Tactile Systems Technology, Inc. Cost of Goods Sold, Sales-type Lease
Tactile Systems Technology, Inc. (TCMD) reported Cost of Goods Sold, Sales-type Lease of $2.72 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSoldSalesTypeLease · last filed 2026-08-10
- Tactile Systems Technology, Inc. cost of goods sold, sales-type lease for the quarter ending 2026-06-30 was $2.72M, a 3.50% increase year-over-year.
- Tactile Systems Technology, Inc. cost of goods sold, sales-type lease for the quarter ending 2026-03-31 was $2.39M, a 17.87% increase year-over-year.
- Tactile Systems Technology, Inc. cost of goods sold, sales-type lease for the quarter ending 2025-12-31 was $3.17M, a 1.21% decline year-over-year.
- Tactile Systems Technology, Inc. cost of goods sold, sales-type lease for the quarter ending 2025-09-30 was $2.86M, a 5.73% increase year-over-year.
- Tactile Systems Technology, Inc. cost of goods sold, sales-type lease for fiscal 2025 was $10.69M, a 6.89% decline from fiscal 2024.
- Tactile Systems Technology, Inc. cost of goods sold, sales-type lease for fiscal 2024 was $11.48M, a 8.71% decline from fiscal 2023.
- Tactile Systems Technology, Inc. cost of goods sold, sales-type lease for fiscal 2023 was $12.58M, a 12.39% increase from fiscal 2022.
- Tactile Systems Technology, Inc. cost of goods sold, sales-type lease for fiscal 2022 was $11.19M, a 16.30% increase from fiscal 2021.
| Period end | Cost of Goods Sold, Sales-type Lease 3 month | Cost of Goods Sold, Sales-type Lease 6 month | Cost of Goods Sold, Sales-type Lease 9 month | Cost of Goods Sold, Sales-type Lease 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.72M 10-Q · filed 2026-08-10 | $5.12M 10-Q · filed 2026-08-10 | $8.29M derived: sum of 3 quarters · filed 2026-08-10 | $11.14M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $2.39M 10-Q · filed 2026-05-04 | $5.57M derived: sum of 2 quarters · filed 2026-05-04 | $8.42M derived: sum of 3 quarters · filed 2026-05-04 | $11.05M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $6.03M derived: sum of 2 quarters · filed 2026-02-17 | $8.66M derived: sum of 3 quarters · filed 2026-08-10 | $10.69M 10-K · filed 2026-02-17 |
| 2025-09-30 | $2.86M 10-Q · filed 2025-11-03 | $5.49M derived: sum of 2 quarters · filed 2026-08-10 | $7.52M 10-Q · filed 2025-11-03 | $10.73M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $2.63M 10-Q · filed 2026-08-10 | $4.66M 10-Q · filed 2026-08-10 | $7.87M derived: sum of 3 quarters · filed 2026-08-10 | $10.57M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $2.03M 10-Q · filed 2026-05-04 | $5.24M derived: sum of 2 quarters · filed 2026-05-04 | $7.95M derived: sum of 3 quarters · filed 2026-05-04 | $10.80M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $5.91M derived: sum of 2 quarters · filed 2026-02-17 | $8.77M derived: sum of 3 quarters · filed 2026-02-17 | $11.48M 10-K · filed 2026-02-17 |
| 2024-09-30 | $2.70M 10-Q · filed 2025-11-03 | $5.55M derived: sum of 2 quarters · filed 2025-11-03 | $8.27M 10-Q · filed 2025-11-03 | $11.72M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $2.85M 10-Q · filed 2025-08-04 | $5.57M 10-Q · filed 2025-08-04 | $9.02M derived: sum of 3 quarters · filed 2026-02-17 | $12.23M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $2.71M 10-Q · filed 2025-05-05 | $6.17M derived: sum of 2 quarters · filed 2026-02-17 | $9.38M derived: sum of 3 quarters · filed 2026-02-17 | $12.56M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $6.67M derived: sum of 2 quarters · filed 2026-02-17 | $9.84M derived: sum of 3 quarters · filed 2026-02-17 | $12.58M 10-K · filed 2026-02-17 |
| 2023-09-30 | $3.21M 10-Q · filed 2024-11-04 | $6.39M derived: sum of 2 quarters · filed 2024-11-04 | $9.12M 10-Q · filed 2024-11-04 | $12.67M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $3.17M 10-Q · filed 2024-08-05 | $5.91M 10-Q · filed 2024-08-05 | $9.46M derived: sum of 3 quarters · filed 2025-02-18 | $12.45M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $2.74M 10-Q · filed 2024-05-06 | $6.29M derived: sum of 2 quarters · filed 2025-02-18 | $9.28M derived: sum of 3 quarters · filed 2025-02-18 | $11.89M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $6.54M derived: sum of 2 quarters · filed 2025-02-18 | $9.15M derived: sum of 3 quarters · filed 2025-02-18 | $11.19M 10-K · filed 2025-02-18 |
| 2022-09-30 | $2.99M 10-Q · filed 2023-11-06 | $5.60M derived: sum of 2 quarters · filed 2023-11-06 | $7.64M 10-Q · filed 2023-11-06 | $10.76M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $2.61M 10-Q · filed 2023-08-07 | $4.65M 10-Q · filed 2023-08-07 | $7.77M derived: sum of 3 quarters · filed 2024-02-20 | $10.20M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $2.04M 10-Q · filed 2023-05-08 | $5.16M derived: sum of 2 quarters · filed 2024-02-20 | $7.59M derived: sum of 3 quarters · filed 2024-02-20 | $9.81M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $5.55M derived: sum of 2 quarters · filed 2024-02-20 | $7.77M derived: sum of 3 quarters · filed 2024-02-20 | $9.62M 10-K · filed 2024-02-20 |
| 2021-09-30 | $2.43M 10-Q · filed 2022-11-07 | $4.65M derived: sum of 2 quarters · filed 2022-11-07 | $6.50M 10-Q · filed 2022-11-07 | $9.45M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $2.22M 10-Q · filed 2022-08-01 | $4.07M 10-Q · filed 2022-08-01 | $7.02M derived: sum of 3 quarters · filed 2023-02-21 | $9.58M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $1.85M 10-Q · filed 2022-05-02 | $4.80M derived: sum of 2 quarters · filed 2023-02-21 | $7.36M derived: sum of 3 quarters · filed 2023-02-21 | $9.18M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $5.51M derived: sum of 2 quarters · filed 2023-02-21 | $7.33M derived: sum of 3 quarters · filed 2023-02-21 | $9.01M 10-K · filed 2023-02-21 |
| 2020-09-30 | $2.56M 10-Q · filed 2021-11-08 | $4.38M derived: sum of 2 quarters · filed 2021-11-08 | $6.06M 10-Q · filed 2021-11-08 | $8.21M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $1.82M 10-Q · filed 2021-08-02 | $3.50M 10-Q · filed 2021-08-02 | $5.65M derived: sum of 3 quarters · filed 2022-02-23 | $7.58M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $1.68M 10-Q · filed 2021-05-03 | $3.83M derived: sum of 2 quarters · filed 2022-02-23 | $5.76M derived: sum of 3 quarters · filed 2022-02-23 | $7.65M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $4.08M derived: sum of 2 quarters · filed 2022-02-23 | $5.97M derived: sum of 3 quarters · filed 2022-02-23 | $7.51M 10-K · filed 2022-02-23 |
| 2019-09-30 | $1.93M 10-Q · filed 2020-11-02 | $3.81M derived: sum of 2 quarters · filed 2020-11-02 | $5.36M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $1.88M 10-Q · filed 2020-08-03 | $3.42M 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $1.54M 10-Q · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |